Tarsus Pharmaceuticals

Tarsus’ Xdemvy is approved by the FDA as the first therapy for common eyelid illness

Source – Tarsus Pharmaceuticals Tarsus Pharmaceuticals has achieved a groundbreaking milestone with the FDA approval of Xdemvy, the first-ever treatment ...